1. Home
  2. GEHC vs A Comparison

GEHC vs A Comparison

Compare GEHC & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GE HealthCare Technologies Inc.

GEHC

GE HealthCare Technologies Inc.

HOLD

Current Price

$81.10

Market Cap

35.8B

Sector

Technology

ML Signal

HOLD

Logo Agilent Technologies Inc.

A

Agilent Technologies Inc.

HOLD

Current Price

$118.32

Market Cap

39.8B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GEHC
A
Founded
1892
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
35.8B
39.8B
IPO Year
2022
1999

Fundamental Metrics

Financial Performance
Metric
GEHC
A
Price
$81.10
$118.32
Analyst Decision
Buy
Buy
Analyst Count
12
16
Target Price
$91.17
$162.31
AVG Volume (30 Days)
3.2M
2.2M
Earning Date
05-06-2026
05-27-2026
Dividend Yield
0.17%
0.86%
EPS Growth
4.84
3.16
EPS
4.55
4.57
Revenue
$20,625,000,000.00
$4,472,000,000.00
Revenue This Year
$7.15
$8.03
Revenue Next Year
$4.53
$6.22
P/E Ratio
$17.68
$25.82
Revenue Growth
4.84
6.43
52 Week Low
$57.65
$96.43
52 Week High
$89.77
$160.27

Technical Indicators

Market Signals
Indicator
GEHC
A
Relative Strength Index (RSI) 45.60 29.17
Support Level $77.55 $115.37
Resistance Level $85.76 $123.79
Average True Range (ATR) 2.28 3.63
MACD 0.19 -0.28
Stochastic Oscillator 48.71 24.28

Price Performance

Historical Comparison
GEHC
A

About GEHC GE HealthCare Technologies Inc.

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).

About A Agilent Technologies Inc.

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

Share on Social Networks: